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Background
A puzzling observation in HIV vaccine research is the
fact that recombinant gp120 is able to adsorb bNAbs
from HIV+ patient sera, but unable to elicit such
bNAbs. To account for its poor immunogenicity, we
wondered if the epitopes recognized by bNAbs might be
proteolyzed in vivo. Cathepsins L, S, and D are the
major proteases responsible for antigen processing and
presentation. Previously, we defined the cathepsin clea-
vage sites on MN rgp120 and found that they co-loca-
lized with epitopes recognized by bNAbs. Although
examination of gp120 sequences suggested that these
sites were conserved, the recognition motifs for cathe-
psins are poorly defined and it was important to verify
their presence by protease digestion studies.
Methods
Purified gp120s from three clades of HIV were digested
with cathepsins L, S, and D. These included envelope
proteins from the from the 108060 (clade B), A244
(CRF01_AE) and 97001 (clade C) isolates. N-terminal
sequencing was used to identify the cathepsin cleavage
sites.
Results
When combined with the previous MN-rgp120 results,
we found that 6 out of 10 cathepsin cleavage sites were
conserved in four viruses from three different clades of
HIV. We found that polymorphisms that inactivate clea-
vage sites often result in the formation of an alternate
nearby site. Although cleavage is an ordered processing
beginning in the V3 domain, the cleavage sites in this
domain are more polymorphic than other sites.
Conclusion
Our results suggest that cathepsin cleavage sites are
highly conserved in gp120 and co-localize to regions
recognized by bNAbs. These results are consistent with
our hypothesis that the poor immunogenicity of gp120
epitopes results from protease digestion in vivo. Current
studies are in progress to determine whether inactiva-
tion of these sites or enzymes may provide a new
approach to improving the immunogenicity of epitopes
recognized by bNAbs.
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